Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (4978)	3/22/1999 3:01:00 PM
From: JanyBlueEyes	Read Replies (2) \| Respond to of 5736

European Activities This is taken from the most recent quarterly report filed on 11/16/98 for the third quarter 1998. In October 1998, the Company initiated clinical trials of the Colormate(R) TLc-BiliTest(TM) at the Beijing OB GYN Hospital in China. The Company has hired two employees in South Africa and in November 1998 initiated clinical trials of the Colormate(R) TLc-BiliTest(TM) in monitoring bilirubinemia at King Edward Hospital in Durban. In addition, in 1998 and early 1999, the Company anticipates commencing multicenter studies of the Colormate(R) TLc-BiliTest(TM) in monitoring bilirubinemia in a number of hospitals located in the United States, England, Israel, Brazil and Argentina.... These studies, as well as those to be conducted in South Africa and Beijing, are being coordinated by Dr. Jeffrey Maisels pursuant to international testing protocols developed by Dr. Maisels. ----- Message 3033819 - Information on Dr. Maisels